Novel drug candidate for the treatment of Inflammatory Bowel Disease with unique mechanisms of action

被引：0
|
作者：
Lee, J. [1 ]
Kim, G. [1 ]
Kim, J. C. [1 ]
Park, J. H. [1 ]
Han, C. [1 ]
Kim, M. [1 ]
机构：
[1] INEXEL Co Ltd, Dept New Drug Dev, Seoul, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P098
引用
收藏
页码：I261 / I261
页数：1
相关论文
共 50 条
  • [1] Probiotics in inflammatory bowel disease: possible mechanisms of action
    Dotan, I
    Rachmilewitz, D
    CURRENT OPINION IN GASTROENTEROLOGY, 2005, 21 (04) : 426 - 430
  • [2] Mechanisms of action of conventional drugs in inflammatory bowel disease
    Egan, LJ
    Inflammatory Bowel Disease: Translation From Basic Research to Clinical Practice, 2005, 140 : 173 - 179
  • [3] Mechanisms of steroid action and resistance in inflammatory bowel disease
    Kelleher, D.
    McManus, R.
    COLITIS: DIAGNOSIS AND THERAPEUTIC STRATEGIES, 2006, 147 : 87 - +
  • [4] Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
    Gao, Caifang
    Liu, Lijuan
    Zhou, Yangyang
    Bian, Zhaoxiang
    Wang, Shengpeng
    Wang, Yitao
    CHINESE MEDICINE, 2019, 14 (1)
  • [5] Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease
    Caifang Gao
    Lijuan Liu
    Yangyang Zhou
    Zhaoxiang Bian
    Shengpeng Wang
    Yitao Wang
    Chinese Medicine, 14
  • [6] Astragalus membranaceus as a Drug Candidate for Inflammatory Bowel Disease: The Preclinical Evidence
    Hou, Min
    Leng, Yufang
    Shi, Yajing
    Tan, Zhiguo
    Min, Xiangzhen
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2023, : 1501 - 1526
  • [7] An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease
    A.P. Sykes
    C. Brampton
    S. Klee
    C.L. Chander
    C. Whelan
    M.E. Parsons
    Inflammation Research, 2000, 49 : 311 - 319
  • [8] An investigation into the effect and mechanisms of action of nicotine in inflammatory bowel disease
    Sykes, AP
    Brampton, C
    Klee, S
    Chander, CL
    Whelan, C
    Parsons, ME
    INFLAMMATION RESEARCH, 2000, 49 (07) : 311 - 319
  • [9] A novel multiomic approach to unravel the mechanisms of action of biologics and tofacitinib in Inflammatory Bowel Disease.
    Baldan-Martin, M.
    Azkargorta, M.
    Aransay, A. M.
    Gil-Redondo, R.
    Moreno-Indias, I.
    Iloro, I.
    Soleto, I.
    Orejudo, M.
    Ramirez, C.
    Lucendo, A. J.
    Gutierrez, C. Rodriguez
    Gutierrez, A.
    Arranz, E. Martin
    Bujanda, L.
    Rodriguez-Lago, I.
    Riestra, S.
    Iglesias-Flores, E.
    Bermejo, F.
    Van Domselaar, M.
    Garcia, M. J.
    Salazar, L. Fernandez
    De Prado, A.
    Calvet, X.
    Torrealba, L.
    Rey, I. Baston
    Pallares, H.
    Ber, Y.
    Carnerero, E. L.
    Casanova, M. J.
    Millet, O.
    Elortza, F.
    Mato, J. M.
    Tinahones, F. J.
    Chaparro, M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I85 - I87
  • [10] Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker
    Danese, S.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S225 - S228
12345